Announcements Trials

Browse Landscape

Phase

Phase NA 64 Phase 2 5 Phase 1 5 Phase 4 3 Phase EARLY_PHASE1 2 Phase 3 2 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Oxaliplatin 49 Fluorouracil 46 Capecitabine 41 Cisplatin 36 Gemcitabine 29 Leucovorin 27 Bevacizumab 21 Drug Therapy 20 Paclitaxel 15 Folfox protocol 15 Radiotherapy 14 Irinotecan 14 apatinib 11 Neoadjuvant Therapy 11 Docetaxel 11 sintilimab 9 S 1 (combination) 9 Trastuzumab 8 Sorafenib 8 Nivolumab 8 Surgical Procedures, Operative 7 Magnetic Resonance Spectroscopy 7 lenvatinib 6 atezolizumab 6 XELOX 6 Cetuximab 6 Albumin-Bound Paclitaxel 6 130-nm albumin-bound paclitaxel 6 tislelizumab 5 pembrolizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Blood Specimen Collection × Gastrointestinal × Clear all

NCT05462613 2024-12-20

REPROGRAM-02

Centre Hospitalier Universitaire de Besancon

Phase 2/3 Recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡